Clinical Trials in Chicago

Showing 11561-11580 of 17,609 trials

Sodium Management in Acute Neurological Injury

NCT01558843

This multicenter, observational, study will enroll severe neurologically injured patients both prospectively and retrospectively. The aims are to identify the percent of neurocritical care patients with sodium levels ≤ 135 mEq/L, describe treatment strategies employed, determine the correlation of clinical factors (i.e. GCS, ICP) with serum sodium concentrations in patients prior to sodium altering therapy, and evaluate outcomes through evaluation of length of stay, discharge disposition, and modified Rankin score (mRS).

This Study is to Understand the Current Practice of Sodium Management in Acute Neurological Injury

Washington University School of Medicine400 participantsStarted Feb 2012

Hartford, Connecticut, United States • New Haven, Connecticut, United States • Miami, Florida, United States +14 more locations

TERMINATEDPhase 32.2 miles

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

NCT01975389

This study evaluates the PCSK9 inhibitor, Bococizumab (PF-04950615;RN316), compared to placebo, in reducing the occurrrence of major cardiovascular events, including cardiovascular death, myocardial infarction, stroke, and unstable angina requiring urgent revascularization in high risk subjects who are receiving background lipid lowering therapy and have cholesterol laboratory values of LDL-C \>/= 100 mg/dL (2.6 mmol/L) or non-HDL-C \>/=130 mg/dL (3.4 mmol/L).

Cardiovascular Disease

Pfizer10,564 participantsStarted Oct 2013

Athens, Alabama, United States • Athens, Alabama, United States • Birmingham, Alabama, United States +1592 more locations

Sodium Management in Acute Neurological Injury

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Find Trials by Condition in Chicago

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

Sorafenib for Hepatopulmonary Syndrome

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

Melody® Transcatheter Pulmonary Valve Post-Approval Study

A Phase2 of A-101 Topical Solution in Subjects With Common Warts

A Comparative Evaluation of the Performance and Fit of Pediatric Face Masks

MEmbranous Nephropathy Trial Of Rituximab

A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock.

A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)

Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors

10003 PRO Current Products

Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta

A Randomized Trial of Effects of Parent Mentors on Insuring Minority Children